| Followers | 73 |
| Posts | 3281 |
| Boards Moderated | 0 |
| Alias Born | 03/16/2014 |
Friday, August 01, 2014 6:56:38 AM
Hi Sitain and thanks for your thoughts.
Looking at historical news and price action I`m amazed you`re still long (but at the same time pleased you are still long)
Agreed the shorts will help a rally when we get good news
and you are dead right re analysts , we had one at Summer St whoever they are , and that person left them and they dropped coverage ... probably fired :)
Whether LP got the right bankers to sell us to the market or not by now should be immaterial , theres been enough data to create
its own momentum , but im convinced the institutional world do not beleive NW will succeed or be bought out .
If you have Bloomberg professional under NWBO research Evaluate Pharama have a NWBO report to buy for around $2000 I think,from May 13 but other than that nothing ....as you said p1ss poor.
Often no news is good news but , being ignored by NW is making me question this position .
We are shareholders , im afraid LP / NW make me feel like a stepping stool rather than a partner ...... not good , not happy .
Looking at historical news and price action I`m amazed you`re still long (but at the same time pleased you are still long)
Agreed the shorts will help a rally when we get good news
and you are dead right re analysts , we had one at Summer St whoever they are , and that person left them and they dropped coverage ... probably fired :)
Whether LP got the right bankers to sell us to the market or not by now should be immaterial , theres been enough data to create
its own momentum , but im convinced the institutional world do not beleive NW will succeed or be bought out .
If you have Bloomberg professional under NWBO research Evaluate Pharama have a NWBO report to buy for around $2000 I think,from May 13 but other than that nothing ....as you said p1ss poor.
Often no news is good news but , being ignored by NW is making me question this position .
We are shareholders , im afraid LP / NW make me feel like a stepping stool rather than a partner ...... not good , not happy .
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
